Douglas Lane & Associates LLC Buys 1,027 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Douglas Lane & Associates LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 85,729 shares of the healthcare conglomerate's stock after purchasing an additional 1,027 shares during the quarter. Douglas Lane & Associates LLC's holdings in UnitedHealth Group were worth $44,900,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $32,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE UNH traded up $2.36 during trading hours on Monday, reaching $304.27. 19,026,389 shares of the stock traded hands, compared to its average volume of 6,836,618. The stock has a 50 day simple moving average of $430.87 and a two-hundred day simple moving average of $492.75. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $276.01 billion, a price-to-earnings ratio of 19.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the business posted $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. KeyCorp cut their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $439.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.